Global Glycomics / Glycobiology Market Size, Share, Forecast Report, 2020-2027

The global glycomics market is estimated to grow from USD 1.0 billion in 2020 to USD 2.0 billion by 2025, at a CAGR of 13.8%. The growth of this market is majorly driven by the increasing research activities on glycomics, rising R&D investments in pharmaceutical and biotechnology companies, growth in the proteomics market. On the other hand, emerging countries such as India and China providing lucrative opportunities for players operating in this segment. However, the high cost of tools is expected to hamper the market growth to a certain extent during the forecast period.
The demand for glycomics products for drug discovery & development is estimated to grow at a high rate during the forecast period
Based on application, the glycomics market is segmented into drug discovery & development, disease diagnostics, and other applications. Drug discovery & development is the largest and the fastest-growing application segment in the market, majorly due to the increasing R&D investments in pharmaceutical and biotechnology companies and the growing number of drug discovery research activities in academic research institutes.

Enzymes segment accounted for the largest share of the glycomics market, by product, in 2019
The market is categorized into five product segments, namely, enzymes, instruments, kits, carbohydrates, and reagents & chemicals. The enzymes segment is expected to dominate the market in 2020 and is projected to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the consumable nature of enzymes and their wide applications in a variety of R&D and drug discovery procedures.
North America is the largest regional market for glycomics
The global glycomics market is segmented into North America (US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, and the Rest of Asia Pacific), and the Rest of the World (Latin America and the Middle East and Africa). In 2020, North America is expected to dominate the global market, followed by Europe. The largest share of North America is mainly attributed to increasing investments in glycomics research, rising R&D investments in pharmaceutical companies for drug discovery and the presence of all key players.

Key Market Players
The prominent players operating in the glycomics market include Merck KGaA (Germany), Agilent Technologies (US), Thermo Fisher Scientific (US), New England Biolabs (US), Shimadzu Corporation (Japan), Takara Bio (Japan), S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), Waters Corporation (US), Asparia Glycomics S.L. (Spain), Bio-Techne (US), Bruker Corporation (US), Danaher Corporation (US), RayBiotech (US), Z Biotech (US), Chemily Glycoscience (US), Dextra Laboratories (UK), Lectenz Bio (US), and Ludger Ltd. (UK).

Merck was the leading player in the market in 2018. Strong business operations across all key regions, coupled with a strong brand image, have made Merck a leading player in this market. Over the last few years, the company has been focusing on R&D activities and invested approximately 2.5–4.0% of its life science revenue on R&D activities. The company has a strong presence in North America and generated 35.1% of its total life science revenue from the North American market in 2018. Also, the company is making strategic investments in high-growth Asian markets to strengthen its Life Science business segment.

Product

• Enzymes
  • Glycosidases & Neuramidases
  • Glycosyltransferases & Sialytransferases
• Other Enzymes (Carbohydrate kinases, carbohydrate sulfotransferases, protein sulfotransferases, and sulfatases)
• Instruments
  • Mass Spectrometry Instruments
  • Chromatography Instruments
  • Arrays
  • Other Instruments (electrophoresis instruments, NMR instruments, and HPLC columns)
• Kits
  • Glycan Releasing Kits
  • Glycan Labeling Kits
  • Glycan Purification Kits
  • Other Kits (glycan detection kits, glycan enrichment kits, and glycan sample preparation kits)
• Carbohydrates
  • Oligosaccharides
  • Monosaccharides
  • Other Carbohydrates (rare sugars, glycoproteins, glycolipids, and glycol peptides)
• Reagents & Chemicals

Application

• Drug Discovery & Development
• Disease Diagnostics
• Other Applications (virology, cell biology, and microbiology)

End-user

• Academic Research Institutes
• Pharmaceutical and Biotechnology Companies
• Clinical Laboratories

Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
• Rest of the World
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
• Middle East & Africa